MiniMed Group, Inc.
Close on Oct 19, 2026
- Market cap
- $5.00B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q1 FY2027 Ended Jul 31, 2026 | Sep 1, 2026 | Before market open | $843.00M | – | – |
| Q4 FY2026 Ended Apr 24, 2026 | Jun 3, 2026 | Before market open | $837.00M | $-0.68 | – |
Company guidance
Outlook given with results on Sep 1, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDA marginnon-GAAP | fiscal year 2027 | 16% | New |
| Organic revenue growthnon-GAAP | fiscal year 2027 | 10.5% growth | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements MiniMed filed with the SEC
NORTHRIDGE, Calif., October 15, 2026
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
MiniMed Delivers Strong Fourth Quarter and Full Fiscal
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
MiniMed announces closing of Initial Public Offering
Material agreement · Acquisition or disposition completed · New financial obligation · Unregistered share sale · Executive or director change · Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K